Strategies Using Off-Patent Antibiotics for Methicillin Resistant S. Aureus "STOP MRSA"

NCT00729937 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

2265

Enrollment

NIH

Sponsor class

Conditions

Staphylococcal Infection

Interventions

DRUG: Cephalexin
DRUG: Clindamycin
OTHER: Placebo
DRUG: Trimethoprim-sulfamethoxazole

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)